Table 4.
Type of ULT | sUA Levels | ||
---|---|---|---|
Baseline | After ULT | Change in sUA | |
Allopurinol users, mg/dL | 7.70 | 7.20 | −0.65 |
Febuxostat users, mg/dL | 7.91 | 6.45 | −1.50 |
Benzbromarone users, mg/dL |
7.34 | 5.83 | −1.64 |
p-Value | 0.147 | 0.020 * | 0.002 * |
* p < 0.05. Values are the number of the variables ± standard deviation. Abbreviations: sUA, serum uric acid; ULT, urate-lowering therapy.